Primary Peritoneal Carcinoma Completed Phase 1 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00060359Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube CancerTreatment
NCT00352300Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma CancerTreatment